Abstract
Background
Plasma volume reduction (PVR) may reduce the risk of hemolysis associated with transfusion of plateletpheresis blood products (PLTs) containing ABO-incompatible plasma. But PVR may delay PLT issue. In collaboration with our blood donor center we evaluated an automated screen of PLT for high-titer ABO antibody and to apply PVR to high-titer PLTs.Study design and methods
At the donor center, plasma from PLT donors was tested using an automated microplate system (PK7300, Beckman). PK settings were set for a detection cutoff equivalent to 1 in 256 using a manual tube method. The donors associated with high-titer PLTs were characterized by sex and age. In the transfusion service, the number of PVR procedures was evaluated before and after implementation of the high-titer screen.Results
During validation, 157 of 1008 PLT units (15%) were positive by the automated method versus 121 (12%) by manual method. After implementation, 2112 of 15,240 PLT units were high-titer, with higher frequency in donations from females versus males (18% vs. 12%, p < 0.0001). The PLT PVR rate was reduced by 50%.Conclusion
Implementation of an automated method to screen PLTs for high-titer ABO antibody at the donor center improves the inventory management of PLTs containing ABO-incompatible plasma at the hospital transfusion service.References
Articles referenced by this article (14)
ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Transfus Apher Sci, (1):83-88 2010
MED: 20034854
Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories.
Arch Pathol Lab Med, (6):909-916 2007
MED: 17550318
How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
Transfusion, (10):2081-2085 2012
MED: 22414003
The impact of apheresis platelet manipulation on corrected count increment.
Transfusion, (6):1221-1227 2012
MED: 22233358
Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction.
Transfus Med, (5):375-379 2006
MED: 16999762
Rapid detection of high titer anti-a/anti-B in blood donors using an Olympus PK 7200 [abstract]
Transfusion, 116A- 2009
A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.
Transfusion, (1):92-96 2011
MED: 20576015
Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.
Transfusion, (9):1845-1849 2009
MED: 19453987
ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
Transfusion, (10):2087-2093 2012
MED: 22339320
Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers.
Transplantation, (12 Suppl):S17-9 2007
MED: 18162980
Show 4 more references (10 of 14)
Citations & impact
Impact metrics
Article citations
Quality improvement with platelet additive solution for safer out-of-group platelet transfusions.
Immunohematology, 35(3):108-115, 01 Sep 2019
Cited by: 7 articles | PMID: 31621370 | PMCID: PMC6816025
Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
Transfusion, 59(6):1911-1915, 13 Mar 2019
Cited by: 9 articles | PMID: 30865314
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
Transfusion, 58(4):891-895, 22 Feb 2018
Cited by: 8 articles | PMID: 29473178
Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
Transfusion, 55(8):1882-1888, 11 Mar 2015
Cited by: 11 articles | PMID: 25757728
A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.
Transfusion, 51(1):92-96, 01 Jan 2011
Cited by: 43 articles | PMID: 20576015 | PMCID: PMC3682925
ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Transfus Apher Sci, 42(1):83-88, 19 Jan 2010
Cited by: 52 articles | PMID: 20034854
Review
